The long-term treatment outcomes of depression and anxiety comorbid with substance abuse

The Journal of Behavioral Health Services & Research
G Bovasso

Abstract

The impact of the comorbidity of psychiatric disorder and substance abuse on treatment outcomes was estimated using data from a longitudinal survey of 1,920 individuals who were followed nearly 15 years. Individuals with anxiety or depression symptoms at baseline generally experienced increased distress at follow-up; those who received mental health treatment experienced decreased distress at follow-up. Individuals with substance abuse/dependence symptoms who received treatment at baseline had a higher risk of follow-up disability; treated individuals with substance abuse who had comorbid anxiety and depression symptoms at baseline were at lower risk of disability at follow-up. Individuals with anxiety and depression symptoms at baseline had a higher incidence of chronic illness during follow-up; those who received treatment or had substance abuse symptoms did not. The results may improve understanding of the degree to which treatment of a primary disorder may prevent the incidence or reduce the prevalence of a secondary comorbid disorder.

References

Aug 1, 1990·The Journal of Nervous and Mental Disease·A Y Tien, J C Anthony
Oct 1, 1989·Acta Psychiatrica Scandinavica·A Dryman, J C Anthony
Sep 1, 1995·Comprehensive Psychiatry·I M GoldenbergM B Keller
Dec 1, 1994·The American Journal of Psychiatry·M A Schuckit, V Hesselbrock
Oct 1, 1993·American Journal of Community Psychology·R C Kessler, R H Price
Jan 1, 1996·The American Journal of Psychiatry·M G Kushner
Jan 1, 1997·Harvard Review of Psychiatry·R J Frances
Feb 21, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A MarkouG F Koob
Nov 7, 1998·The Australian and New Zealand Journal of Psychiatry·N Siegfried
Apr 6, 1999·Social Psychiatry and Psychiatric Epidemiology·M A BadawiJ Gallo

❮ Previous
Next ❯

Citations

Jun 6, 2006·The Journal of Behavioral Health Services & Research·Jennifer W YuMarie C McCormick
Nov 25, 2003·Journal of Substance Abuse Treatment·Avram Goldstein, Byron W Brown
Mar 22, 2003·Schizophrenia Research·Renee D GoodwinJack M Gorman
May 10, 2006·Journal of Psychoactive Drugs·Russel S FalckHarvey A Siegal
Jul 16, 2008·Epidemiologic Reviews·Magdalena CerdáSandro Galea
Jul 19, 2011·General Hospital Psychiatry·Antoni BulbenaOscar Vilarroya
Aug 2, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Geetha A SubramaniamMarc J Fishman
Sep 2, 2005·Journal of Substance Abuse Treatment·Christopher W ShanahanJeffrey H Samet
Mar 19, 2008·Expert Review of Neurotherapeutics·David J Castle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
C Eldon TaylorCheryl Clemence
Child and Adolescent Psychiatric Clinics of North America
Oliver Stroeh, Harsh K Trivedi
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners
K Feroli, S Hobson
© 2021 Meta ULC. All rights reserved